Journal profile · PERIPHERAL VASCULAR DISEASE
Vascular Health and Risk Management
ISSN 1176-6344 · eISSN 1178-2048 · Dove Medical Press · United Kingdom
Vascular Health and Risk Management: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.1 (journal website); JCR Q2 (journal website); fully open access; APC about USD 3,940; median 100 days to acceptance (106 articles, last 24 months); acceptance rate 24% (journal website); 89 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Vascular Health and Risk Management is published by Dove Medical Press and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Lipoproteins and Cardiovascular Health and Diabetes, Cardiovascular Risks, and Lipoproteins, together about 24.4% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Professor Mirna N. Chahine Vascular Health and Risk Management is an international, peer-reviewed open access journal focusing on the maintenance of vascular health, disease prevention, risk factors, therapeutics, monitoring and risk management of vascular disease and its sequelae. The journal also seeks to address the association between lifestyle, hypertension, vascular biology, metabolic syndrome, obesity, aging, and vascular health & disease. The journal considers studies on drugs, drug design and development, and therapeutic use. Vascular Health and Risk Management will no longer consider meta-analyses and Mendelian Randomisation (MR) studies for publication. Specific topics covered by the journal include:• Assessment of cardiovascular risk factors• Management and monitoring of cardiovascular risk factors• Methods for arterial evaluation and risk factorsThe journal welcomes original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary. Updated 6 August 2025
From the journal's Aims & Scope
Research area (LetPub): PERIPHERAL VASCULAR DISEASE
Editor-in-chief Mirna N. ChahinePublisher website
Editorial board by country: 4 in mainland China (about 6%); most named United States 16, United Kingdom 7, India 6, France 5, Mainland China 4 (70 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine10.8%
- Lipoproteins and Cardiovascular HealthMedicine6.9%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine6.8%
- Venous Thromboembolism Diagnosis and ManagementMedicine6.6%
- Cardiovascular Health and Disease PreventionMedicine6.4%
- Peripheral Artery Disease ManagementMedicine5.9%
- Atrial Fibrillation Management and OutcomesMedicine4.9%
- Acute Myocardial Infarction ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SJR, CiteScore, Impact FactorPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.1Publisher website ·
- 5-year impact factor (publisher)
- 5.2Publisher website ·
- CiteScore 2026-06
- 5.2LetPub ·
- CiteScore (publisher) 2025
- 1.44Publisher website ·
- SJR 2026-06
- 0.91LetPub ·
- SNIP 2026-06
- 1.44LetPub ·
- h-index
- 99OpenAlex ·
- i10-index
- 1,046OpenAlex ·
- 2-year mean citedness
- 2.39OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.53%LetPub ·
Volume
- Articles per year
- 85LetPub ·
- Downloads per year (publisher)
- 168,855Publisher website ·
Articles by year OpenAlex count · 1,640 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 79 | 79 | 45 |
| 2025 | 89 | 89 | 203 |
| 2024 | 53 | 53 | 281 |
| 2023 | 86 | 86 | 1,094 |
| 2022 | 86 | 86 | 1,183 |
| 2021 | 81 | 81 | 1,593 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
100 daysMedian, submission to acceptance · P25–P75 83 days – 124 days
- Acceptance to online
- median 13 days (106 articles)
- Submission to online
- median 124 days
- Sample
- 106 articles with submission and acceptance dates (183 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 24%Publisher website ·
- Desk decision
- 61 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,320 | — | — | |
| LetPub | USD 2,990 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted3
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- original researchOriginal ResearchLength not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePublication ethics, Open access, Plagiarism
- Publication ethics
COPE member Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·- Open access
Open access Model summary
Open access peer-reviewed scientific and medical journals.
Source ↗Publisher website ·- Plagiarism
All submitted manuscripts are checked for plagiarism using Crossref Similarity Check (powered by iThenticate). Model summary
Please be aware that Dove Medical Press checks ALL submitted manuscripts for plagiarism. We use Crossref Similarity Check (powered by iThenticate).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1176-6344
- Electronic ISSN
- 1178-2048
- Society / sponsor
- International Society of Vascular Health
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Vascular Health and Risk Management
What CAS zone is Vascular Health and Risk Management in?
In the 2025 upgraded edition of the CAS Journal Ranking, Vascular Health and Risk Management is in Zone 3 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Vascular Health and Risk Management?
The journal's website gives an impact factor of 3.1 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.2, h-index 99.
How long does peer review take at Vascular Health and Risk Management?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 83–124 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 24%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Vascular Health and Risk Management in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Where are the editorial board members of Vascular Health and Risk Management based?
Of the 70 board members whose country the journal's board page names, 4 (about 6%) are in mainland China; the countries named most often are United States (16), United Kingdom (7) and India (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Vascular Health and Risk Management?
According to LetPub and DOAJ records, Vascular Health and Risk Management is indexed in ESCI, Scopus and DOAJ.
Is Vascular Health and Risk Management open access, and what is the APC?
Vascular Health and Risk Management is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .